Stock Taper 
MREO
$0.25
▼ DOWN 7.17% (-0.02)
KEY STATISTICS
Market Cap$40.30 M
52w High$2.37
52w Low$0.20
Dividend Yield—
Frequency—
P/E-5.05
Volume1.51M
Shares Out.159.62M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Denise Vera Scots-Knight
COMPENSATION 2026
Salary$642,917
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$88,603
Total$2,732,540
ABOUT
SECTOR
Healthcare
WENT PUBLIC
April 24, 2019
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
39
PRICE TARGET
Target High$8.00
Target Low$0.50
Target Median$2.50
Target Consensus$3.25
UPCOMING EARNINGS
DateNov 9, 2026
DayMonday
Rev. Est.$863.83K
NOV
9
MON
PRICE
$0.25 ▼ DOWN 7.17% (−$0.02)About Mereo BioPharma Group plc
https://www.mereobiopharma.com ↗Mereo BioPharma Group develops and commercializes therapeutics for oncology and rare diseases, with candidates in various clinical trial phases, including etigilimab, Navicixizumab, and others, based in London.
INDUSTRY
Biotechnology
A PRODUCT MEREO BIOPHARMA GROUP PLC IS KNOWN FOR
Setrusumab (UX143)
Setrusumab, Mereo BioPharma's leading late-stage monoclonal antibody candidate, is being developed to treat osteogenesis imperfecta, with recent Phase 3 trial results announced.
Revenue by Products
| Icon | PRODUCT | Q2-2025 |
|---|---|---|
 | Operating Segments | $500K |
ETFS HOLDING THIS STOCK
ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
70.50%
HOLDERS
119
TOP 12 OF 119 · RANKED BY POSITION SIZE
Janus Henderson Group Plc
Rubric Capital Management LP
683 Capital Management, LLC
Ecor1 Capital, LLC
Frazier Life Sciences Management, L.P.
Bank Of America Corp /De/
Mangrove Partners
Newtyn Management, LLC
Schonfeld Strategic Advisors LLC
Abrdn Plc
Rock Springs Capital Management LP
Clearline Capital LP
RATINGS SNAPSHOT
Overall rating: B-
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2
INSIDER TRADES
★
DIRECTOR
PAKIANATHAN DEEPIKA
Purchase · 66.0K shares
2026-02-26
★
DIRECTOR
Jenkins Annalisa
Purchase · 106.8K shares
2026-02-26
★
DIRECTOR
Jenkins Annalisa
Purchase · 66.0K shares
2026-02-26
★
DIRECTOR
WYZGA MICHAEL S
Purchase · 66.0K shares
2026-02-26
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
UNDERWEIGHT 1
HOLD 1
MARKET PERFORM 1
5 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 CADL | $13.07 | COMPARE |
 CTNM | $17.05 | COMPARE |
 SLN | $13.42 | COMPARE |
 CAPR | $9.59 | COMPARE |
 KYTX | $8.37 | COMPARE |
 LXEO | $4.86 | COMPARE |
 ACIU | $2.65 | COMPARE |
 PRQR | $2.29 | COMPARE |